LEXXW vs SBAC · rev $705.9K vs P/E 30, rev $719.6M
Lexaria Bioscience Corp (LEXXW) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
Latest reported SBAC revenue for 2025-12-31 was $719.6M. Net income was $370.3M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
LEXXW currently screens at market cap $33.8M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the LEXXW and SBAC stock pages for the full models.
Not investment advice.